Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.5K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.5K
Abnormal Proliferation02:23

Abnormal Proliferation

4.7K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.4K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing Antiseizure Candidate Compounds Using Deuterium Substitution.

ACS central science·2026
Same authorSame journal

An Abnormal Clone with a der(12;22)(q10;q10) as a Rare Abnormality Within the Context of dup(1)(q25q43), Deletion of ABL1 and a t(8;21) in a Pediatric Male Patient with Acute Myeloid Leukemia.

Journal of the Association of Genetic Technologists·2026
Same author

Complex Chromothripsis-like Features in Plasma Cell Myeloma: A Case Report and Review of the Literature.

Diagnostics (Basel, Switzerland)·2026
Same author

A Rare Case of De Novo Acute Myeloid Leukemia, Featuring a <i>KMT2A</i> (<i>MLL</i>) Amplification.

Diagnostics (Basel, Switzerland)·2026
Same author

Epigenetics in B-CLL.

International journal of genomics·2026
Same author

Barriers and facilitators to implementing a pilot produce prescription program in a community health setting in Toronto, Canada.

BMC primary care·2025

Related Experiment Video

Updated: Oct 10, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

327

c-MYC Amplification in AML.

Ruby Tang1,2, Amy Cheng1,2, Fabian Guirales1,3

  • 1The International Circle of Genetics Studies, Los Angeles, CA.

Journal of the Association of Genetic Technologists
|December 13, 2021
PubMed
Summary
This summary is machine-generated.

MYC amplification is a rare genetic abnormality in acute myeloid leukemia (AML). This review explores its associated cytogenetic features, patient demographics, and clinical significance in AML management.

More Related Videos

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.2K
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.1K

Related Experiment Videos

Last Updated: Oct 10, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

327
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.2K
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.1K

Area of Science:

  • Hematology
  • Cancer Genetics
  • Molecular Oncology

Background:

  • Acute myeloid leukemia (AML) is a myeloid precursor clonal disorder.
  • Cytogenetic aberrations are crucial for AML classification and risk stratification.
  • MYC amplification, a rare event (<1% of AML), presents unique clinicopathologic associations.

Purpose of the Study:

  • To review recurrent cytogenetic abnormalities associated with MYC amplification in AML.
  • To explore demographic characteristics of AML patients with MYC amplification.
  • To discuss the diagnostic and therapeutic implications of MYC amplification in AML.

Main Methods:

  • Literature review of studies on MYC amplification in AML.
  • Analysis of cytogenetic data and patient demographics.
  • Synthesis of findings regarding clinical significance and therapeutic targets.

Main Results:

  • MYC amplification occurs in <1% of AML, often as double minutes, ring/marker chromosomes, or homogeneously staining regions.
  • Associated aberrations include trisomies 4 and 6, sex chromosome aneusomy, and complex karyotypes.
  • MYC amplification is linked to negative prognostic factors like advanced age.

Conclusions:

  • MYC amplification represents a distinct genetic event in AML with significant prognostic implications.
  • Understanding these associations aids in AML diagnosis, risk stratification, and targeted therapy development.
  • Further research is needed to elucidate the full clinical impact and therapeutic potential of targeting MYC in AML.